This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| International Consolidated Airlines Group S.A. | 149.7 | 2.6% |
| Rs Group PLC | 869.8 | 2.5% |
| Ocado Group PLC | 521.8 | 2.3% |
| Smurfit Kappa Group PLC | 3,046.0 | 2.3% |
| Weir Group PLC | 1,930.0 | 2.0% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Barclays PLC | 154.2 | -2.3% |
| Abrdn PLC | 202.9 | -2.3% |
| Melrose Industries PLC | 163.0 | -2.3% |
| St. James’s Place PLC | 1,197.5 | -2.1% |
| Prudential PLC | 1,146.0 | -2.0% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,887 | 0.2% | 3.6% |
| DOW JONES INDUS. AVG | 33,916 | 0.1% | -1.6% |
| DAX INDEX | 15,806 | 0.0% | 11.4% |
| NIKKEI 225 | 28,515 | 0.1% | 6.4% |
| S&P/ASX 200 INDEX | 7,382 | 0.3% | -1.9% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 81.75 | -0.93% |
| Brent Crude (ICE) | USD/bbl. | 85.60 | -0.82% |
| Gold Spot | USD/t oz. | 1,986 | -0.9% |
| Copper (Comex) | USd/lb. | 407 | -0.9% |
Click graph to enlarge
The UK 100 called to open +13 points at 7892. The UK100 looks set to open higher as Chinese GDP figures came in stronger than expected. China’s economy expanded at a faster rate than economists forecasts with GDP in the first quarter up 4.5% year on year. Stateside yesterday saw stocks closed higher on as investors look ahead to a hefty week of corporate news. The Dow Jones closed up 100.71 points, or 0.3%, at 33,987.18. The S&P gained 13.68 points, or 0.3%, to 4,151.32, while the Nasdaq advanced 34.26 points, or 0.3%, at 12,157.72.
EasyJet have forecast a profit for the financial year 2023 to be ahead of market expectations, encouraged by strong demand during the Easter weekend despite French strikes and strong bookings for the summer. They report that market expectations for profit stands at about £260m for fiscal 2023.
Entain notes strong start to 2023 with Q1 group net gaming revenue up 15%.
GSK will buy Canada-based late-stage biopharma firm Bellus Health Inc in an all-cash deal for $2bn.
Mitie expects their FY23 revenue to be “slightly above prior year” of £4bn. They expect their operating profit to be at least £155m; previously at least £145m.
Moneysupermarket.com says their Q1 2023 revenue has increased by 15% to £106.3m, supported by recovery in insurance and travel. They expect to deliver FY market expectations.
THG report a 2022 pretax loss of £549.7m, widening from £186.3m YoY. They have provided no further update on Apollo’s takeover proposal.
No new broker comments
UK
IntegraFin Holdings
Ninety One
US
Bank of America Corp
Goldman Sachs
Johnson & Johnson
Intuitive Surgical
Netflix
UK
Antofagasta
Entain
Hunting
Network International Holdings
Quilter
US
Morgan Stanley
International Business Machines
Tesla
Chinese Gross Domestic Product
Chinese Industrial Production
Chinese Retail Sales
UK Claimant Count Change
UK ILO Unemployment Rate
EU ZEW Survey – Economic Sentiment
German ZEW Survey – Current Situation
US Building Permits
US Housing Starts
Fed's Bowman speech
UK 100 companies going ex-dividend on 20th April 2023:
Antofagasta
BAE Systems
Weir Group
Spirax-Sarco Engineering
London Stock Exchange Group
UK 250 companies going ex-dividend on 20th April 2023:
Vanquis Banking Group
Vistry Group
Quilter
Vesuvius
Ibstock
Genuit Group
Videndum
Rathbones Group
Bodycote
Drax Group
Supermarket Income REIT
Foresight Solar Fund
Hunting
Merchants Trust
Schroder Oriental Income Fund
JPMorgan American Investment Trust
Jupiter Fund Management
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.